Renal allotransplantation in humans. I. Systemic immunosuppressive therapy.
D058186:Acute Kidney Injury / Q000209:etiology; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D003609:Dactinomycin / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007677:Kidney Function Tests; D016030:Kidney Transplantation; D008297:Male; D008722:Methods; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use*; D012077:Renal Artery; D013997:Time Factors; D014019:Tissue Donors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D003609:Dactinomycin; D006493:Heparin; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone